Pacer Advisors, Inc. Corcept Therapeutics Inc Transaction History

Pacer Advisors, Inc.

  • $41.8 Billion
  • Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 9,207 shares of CORT stock, worth $473,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,207
Previous 3,852 139.02%
Holding current value
$473,239
Previous $125,000 240.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$29.51 - $46.26 $158,026 - $247,722
5,355 Added 139.02%
9,207 $425,000
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $60,588 - $94,061
2,728 Added 242.7%
3,852 $125,000
Q1 2024

May 10, 2024
SELL
$21.1 - $27.46 $3,650 - $4,750
-173 Reduced 13.34%
1,124 $28,000
Q4 2023

Jan 16, 2024
SELL
$24.82 - $32.88 $2,928 - $3,879
-118 Reduced 8.34%
1,297 $42,000
Q3 2023

Nov 13, 2023
BUY
$21.97 - $33.8 $16,565 - $25,485
754 Added 114.07%
1,415 $38,000
Q2 2023

Jul 12, 2023
SELL
$21.44 - $25.15 $11.1 Million - $13.1 Million
-518,895 Reduced 99.87%
661 $14,000
Q1 2023

May 02, 2023
BUY
$19.2 - $24.47 $1.17 Million - $1.49 Million
61,087 Added 13.32%
519,556 $11.3 Million
Q4 2022

Feb 06, 2023
BUY
$19.95 - $29.96 $2.97 Million - $4.46 Million
148,864 Added 48.08%
458,469 $9.31 Million
Q3 2022

Oct 18, 2022
SELL
$24.7 - $29.12 $1.33 Million - $1.56 Million
-53,698 Reduced 14.78%
309,605 $7.94 Million
Q2 2022

Aug 12, 2022
BUY
$17.33 - $25.3 $1.78 Million - $2.6 Million
102,693 Added 39.4%
363,303 $8.64 Million
Q1 2022

Apr 05, 2022
BUY
$16.53 - $25.21 $187,615 - $286,133
11,350 Added 4.55%
260,610 $5.87 Million
Q4 2021

Feb 03, 2022
BUY
$17.1 - $23.34 $4.26 Million - $5.82 Million
249,260 New
249,260 $4.94 Million
Q4 2020

Jan 20, 2021
SELL
$16.78 - $27.3 $307,527 - $500,327
-18,327 Closed
0 $0
Q3 2020

Oct 19, 2020
BUY
$12.46 - $19.98 $27,436 - $43,995
2,202 Added 13.66%
18,327 $319,000
Q2 2020

Jul 29, 2020
BUY
$11.0 - $18.26 $11,638 - $19,319
1,058 Added 7.02%
16,125 $271,000
Q1 2020

Apr 23, 2020
SELL
$10.11 - $14.04 $148,707 - $206,514
-14,709 Reduced 49.4%
15,067 $190,000
Q4 2019

Feb 10, 2020
SELL
$12.06 - $16.96 $66,245 - $93,161
-5,493 Reduced 15.57%
29,776 $360,000
Q3 2019

Oct 10, 2019
SELL
$10.41 - $14.66 $35,060 - $49,374
-3,368 Reduced 8.72%
35,269 $499,000
Q2 2019

Aug 12, 2019
SELL
$9.78 - $12.76 $9,643 - $12,581
-986 Reduced 2.49%
38,637 $431,000
Q1 2019

Apr 10, 2019
BUY
$10.03 - $15.71 $152,837 - $239,388
15,238 Added 62.49%
39,623 $465,000
Q4 2018

Feb 13, 2019
BUY
$11.29 - $17.19 $120,419 - $183,348
10,666 Added 77.75%
24,385 $326,000
Q3 2018

Nov 14, 2018
BUY
$12.27 - $15.65 $168,332 - $214,702
13,719 New
13,719 $192,000

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email